JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.97% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TA
3301
DELISTED
TravelCenters of America LLC
TA
| $2.04M | ﹤0.01% |
71,454
+67,219
| +1,587% | +$1.54M |
|
|
QTNT
3302
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.04M | ﹤0.01% |
6,738
-1,494
| -18% | -$448K |
|
|
CARB
3303
DELISTED
Carbonite Inc
CARB
| $2.03M | ﹤0.01% |
56,973
+51,554
| +951% | +$1.98M |
|
3304
Viridian Therapeutics
VRDN
$2.49B
| $2.03M | ﹤0.01% |
24,197
+476
| +2% | +$44.9K |
|
3305
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$339M
| $2.02M | ﹤0.01% |
26,334
+15,448
| +142% | +$1.17M |
|
3306
Vanguard Total World Stock ETF
VT
$81.9B
| $2.02M | ﹤0.01% |
26,647
+2,923
| +12% | +$220K |
|
3307
Ironwood Pharmaceuticals
IRWD
$674M
| $2.02M | ﹤0.01% |
130,665
-555,490
| -81% | -$8.78M |
|
|
ACR
3308
ACRES Commercial Realty
ACR
$101M
| $2.02M | ﹤0.01% |
61,298
+19,140
| +45% | +$642K |
|
|
AD
3309
Array Digital Infrastructure
AD
$3.09B
| $2.02M | ﹤0.01% |
45,046
+21,613
| +92% | +$872K |
|
3310
Regis Corp
RGS
$70.1M
| $2.02M | ﹤0.01% |
4,936
-19,790
| -80% | -$7.58M |
|
|
NXEO
3311
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $2.02M | ﹤0.01% |
164,495
+58,041
| +55% | +$580K |
|
|
ADAP
3312
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.01M | ﹤0.01% |
148,525
-63,465
| -30% | -$665K |
|
3313
Dave & Buster's
PLAY
$370M
| $2.01M | ﹤0.01% |
30,407
-219,657
| -88% | -$11.9M |
|
3314
Foster
FSTR
$404M
| $2.01M | ﹤0.01% |
97,813
+778
| +0.8% | +$17.8K |
|
3315
CALL
Colgate-Palmolive
CL
$74.1B
| $2.01M | ﹤0.01% |
30,000
| – | – |
|
3316
Evolution Petroleum
EPM
$135M
| $2M | ﹤0.01% |
181,355
+141,754
| +358% | +$1.49M |
|
3317
CALL
Cummins
CMI
$87B
| $2M | ﹤0.01% |
13,700
| – | – |
|
3318
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$461M
| $2M | ﹤0.01% |
59,533
+30,000
| +102% | +$1.01M |
|
3319
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.62B
| $1.99M | ﹤0.01% |
20,028
-42
| -0.2% | -$3.96K |
|
|
CIO
3320
DELISTED
City Office REIT
CIO
| $1.99M | ﹤0.01% |
157,797
+145,624
| +1,196% | +$1.86M |
|
3321
CALL
Sempra
SRE
$56.5B
| $1.99M | ﹤0.01% |
35,000
-154,000
| -81% | -$8.91M |
|
3322
Kosmos Energy
KOS
$1.51B
| $1.98M | ﹤0.01% |
211,853
+37,811
| +22% | +$319K |
|
3323
CALL
AstraZeneca
AZN
$244B
| $1.98M | ﹤0.01% |
+25,000
| New | +$1.89M |
|
3324
Bloom Energy
BE
$69.6B
| $1.97M | ﹤0.01% |
+57,691
| New | +$1.61M |
|
|
SRE.PRA
3325
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $1.97M | ﹤0.01% |
+19,500
| New | +$2M |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.